The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
MedPage Today on MSN
Evolocumab Reduced First CV Events in Patients Without Prior MI or Stroke
N EW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback